Literature DB >> 2425255

5-Azacytidine: survival and induction of the SOS response in Escherichia coli K-12.

J Barbé, I Gibert, R Guerrero.   

Abstract

Survival and induction of the SOS system by 5-azacytidine, an analog of cytidine, were studied in Escherichia coli K-12. This compound did not produce any effect on the viability of dcm and dam dcm mutants. Furthermore, recA430 and lexA1 strains (both mutations interfere with LexA repressor cleavage but not recombination proficiency) were more resistant than the wild-type strain of E. coli K-12. In contrast, recBC and recA13 mutants were more sensitive to 5-azacytidine than the wild type. Transient exposure of E. coli to 5-azacytidine for 60 min induced both recA-dependent inhibition of cell division and induction of lambda prophage in Dcm+ strains but not in Dcm- mutants. Expression of both functions was dependent on recBC exonuclease. On the other hand, 5-azacytidine was unable to trigger the induction of umuCD and mucB genes and no amplification of RecA protein synthesis in either Dcm+ or Dcm- strains was observed. These last results are in agreement with previously reported data suggesting that there is a discrimination in the expression of the several SOS functions and that some SOS genes may be induced without amplification of RecA protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425255     DOI: 10.1016/0167-8817(86)90035-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  10 in total

1.  Importance of the tmRNA system for cell survival when transcription is blocked by DNA-protein cross-links.

Authors:  H Kenny Kuo; Rachel Krasich; Ashok S Bhagwat; Kenneth N Kreuzer
Journal:  Mol Microbiol       Date:  2010-09-16       Impact factor: 3.501

2.  Exploring Synergy between Classic Mutagens and Antibiotics To Examine Mechanisms of Synergy and Antibiotic Action.

Authors:  Lisa Yun Song; Sara D'Souza; Karen Lam; Tina Manzhu Kang; Pamela Yeh; Jeffrey H Miller
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

3.  Induction of the SOS response in Escherichia coli by azidothymidine and dideoxynucleosides.

Authors:  S W Mamber; K W Brookshire; S Forenza
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  DNA of Drosophila melanogaster contains 5-methylcytosine.

Authors:  H Gowher; O Leismann; A Jeltsch
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

5.  Use of Drosophila deoxynucleoside kinase to study mechanism of toxicity and mutagenicity of deoxycytidine analogs in Escherichia coli.

Authors:  Brittany Betham; Sophia Shalhout; Victor E Marquez; Ashok S Bhagwat
Journal:  DNA Repair (Amst)       Date:  2009-12-11

6.  Induction of EcoRII methyltransferase: evidence for autogenous control.

Authors:  S Friedman; S Som
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

7.  Substitutions of a cysteine conserved among DNA cytosine methylases result in a variety of phenotypes.

Authors:  M W Wyszynski; S Gabbara; A S Bhagwat
Journal:  Nucleic Acids Res       Date:  1992-01-25       Impact factor: 16.971

8.  Genetic analysis of the 5-azacytidine sensitivity of Escherichia coli K-12.

Authors:  A S Bhagwat; R J Roberts
Journal:  J Bacteriol       Date:  1987-04       Impact factor: 3.490

Review 9.  Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation.

Authors:  Giovanni L Gravina; Claudio Festuccia; Francesco Marampon; Vladimir M Popov; Richard G Pestell; Bianca M Zani; Vincenzo Tombolini
Journal:  Mol Cancer       Date:  2010-11-25       Impact factor: 27.401

10.  5-azacytidine induces transcriptome changes in Escherichia coli via DNA methylation-dependent and DNA methylation-independent mechanisms.

Authors:  Kevin T Militello; Robert D Simon; Alexandra H Mandarano; Anthony DiNatale; Stacy M Hennick; Justine C Lazatin; Sarah Cantatore
Journal:  BMC Microbiol       Date:  2016-06-27       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.